Achieve high transfection efficiencies and viabilities in almost every cell type. Our R&D facility in Cologne, Germany, invented Nucleofection™, the non-viral transfection technology that is now employed by leading labs worldwide. Combining Nucleofection™ and thorough processes, Lonza's transfection expertise helps meet your milestones and research objectives.
Proven Expertise and a Diverse Offering
- Validated stable clones - Meet your deadlines faster
- Transiently transfected cell lines and primary cells - Achieve high transfection efficiency
- Optimized Nucleofection™ protocols - Let us do the optimization for your cell type of interest
- Assay ready cells cryopreserved in multi-well plates - Speed up your assay development
Contact us for more detailed information.